Why the study?
The study was designed to test the hypothesis that coronary microvascular endothelial dysfunction is associated with epicardial coronary atherosclerosis.
Is coronary microvascular endothelial dysfunction associated with vulnerable plaque characteristics in patients with non-obstructive CAD?
Is coronary microvascular endothelial dysfunction associated with vulnerable plaque characteristics in patients with non-obstructive CAD?
Coronary microvascular endothelial dysfunction is independently associated with vulnerable plaque characteristics in patients with non-obstructive CAD, suggesting a pathophysiological link between microvascular dysfunction and epicardial atherosclerosis.
CMED was associated with vulnerable plaques in non-obstructive CAD; leaves open causal role and need for prospective studies.
AIMS: The aim of this study was to test the hypothesis that coronary microvascular endothelial dysfunction (CMED) is associated with epicardial coronary atherosclerosis. METHODS AND RESULTS: We performed a cross-sectional analysis of a comprehensive invasive assessment of coronary physiology with a focus on endothelium-dependent coronary microvascular function and virtual-histology intravascular ultrasound (VH-IVUS) in a total of 148 consecutive patients with chest pain and angiographically normal coronary arteries or non-obstructive coronary artery disease (CAD). Endothelium-dependent coronary vascular reactivity was evaluated by graded doses of intracoronary acetylcholine (ACh). CMED was defined as a percent increase in coronary blood flow of ≤50% in response to ACh. Patients with CMED (n=87) showed more vulnerable plaque characteristics as compared to those without (n=61); they showed higher plaque burden in association with larger necrotic core volume and higher frequency of imaged arteries containing at least one VH-IVUS-derived thin-capped fibroatheroma (TCFA) (n=22 [25.3%] vs 5 [8.2%], p=0.008). Multivariate logistic regression analysis revealed that CMED was an independent predictor of VH-IVUS-derived TCFA (adjusted odds ratio 2.28 [95% confidence interval: 1.30-4.02], p=0.004). CONCLUSIONS: Independently of conventional coronary risk factors, CMED was associated with vulnerable plaque characteristics in patients with non-obstructive CAD.
No takes yet. Share an insight, caveat, or question.
Godo et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: